Beyond Air, Inc.
XAIRBeyond Air, Inc. in brief
Beyond Air, Inc. is a listed company in the Medical Equipment industry, based in Garden City, New York, USA. Its market value was $4 M on 30 October 2026, which makes it the 27,230th largest listed company in the world and the 4,439th largest in the USA on this site. In the year to March 2026 it had sales of $8 M and a net loss of $33 M. It employs about 54 people and Robert Scott Goodman is its chief executive. Its shares trade under the symbol XAIR (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Beyond Air, Inc.
We are a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide generators and delivery systems capable of generating NO from ambient air. The Company’s first device, LungFit® PH received premarket approval from the FDA in June 2022. The NO generated by the LungFit® PH system is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents. This condition is commonly referred to as persistent pulmonary hypertension of the newborn. The LungFit® platform can generate NO up to 400 parts per million for delivery to a patient’s lungs directly or via a ventilator. LungFit® can deliver NO either continuously or for a fixed amount of time at various flow rates and has the ability to either titrate dose on demand or maintain a constant dose. In July 2022, we commenced marketing LungFit® PH in the United States for PPHN as a medical device.
From the company's annual report filed with the US SEC: read the report
Beyond Air, Inc. timeline
- 2015
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2016
- ✎Renamed AIT Therapeutics, Inc.Formerly KokiCare, Inc..
- 2019
- ✎Renamed Beyond Air, Inc.Formerly AIT Therapeutics, Inc..
Events of Beyond Air, Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,877 (Jan 2020) · #3,742 (Jan 2021) · #3,726 (Jan 2022) · #3,750 (Dec 2022) · #4,137 (Jul 2023) · #3,996 (Jan 2024) · #2,390 (Mar 2026) · #4,099 (Aug 2026) · #4,388 (Oct 2026) · #4,439 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 0.5×
- Price / book
- 0.6×
- Free cash flow yield
- -485.1%
- Net margin (TTM)
- -407.6%
- Operating margin
- -378.1%
- Return on equity
- -544.5%
- Liabilities / assets
- 82.5%
- Net debt
- $6M
- Revenue growth
- +107.6%
- R&D / revenue
- 133.3%
- Revenue per employee
- $142 K
- Profit per employee
- $-616 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Mar 2026 | $8M | +107.6% | $-29M | $-33M | -432.9% |
| Mar 2025 | $4M | +219.0% | $-45M | $-47M | -1260.0% |
| Mar 2024 | $1M | — | $-63M | $-60M | -5193.1% |
| Mar 2023 | — | — | $-52M | $-56M | — |
| Mar 2022 | — | — | $-41M | $-43M | — |
| Mar 2021 | $1M | -37.4% | $-22M | $-23M | -2629.9% |
| Mar 2020 | $1M | -82.0% | $-18M | $-20M | -1434.5% |
| Mar 2019 | $8M | — | $-3M | $-7M | -85.0% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Mar 2026 | $-18M | $1M | $-19M | $-4.01 | — |
| Mar 2025 | $-38M | $6M | $-44M | $-13.77 | — |
| Mar 2024 | $-56M | $6M | $-62M | $-1.82 | — |
| Mar 2023 | $-33M | $4M | $-37M | $-1.86 | — |
| Mar 2022 | $-23M | $1M | $-25M | — | — |
| Mar 2021 | $-20M | $1M | $-21M | $-1.27 | — |
| Mar 2020 | $-15M | $0M | $-15M | $-1.78 | — |
| Mar 2019 | $1M | $0M | $1M | $-0.77 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $2M (+27.5% on a year earlier), net income $-8M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 12, 202610-QQuarterly report · period to Sep 2026
- Oct 30, 2026DEF 14AProxy statement
- Oct 8, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Sep 24, 20268-KCurrent reportMaterial agreement · Directors or officers changed
- Aug 18, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Aug 13, 202610-QQuarterly report · period to Jun 2026
- Aug 6, 20268-KCurrent reportOther events
- Jul 31, 20268-KCurrent reportMaterial agreement · Unregistered share sale · Other events
- Jul 9, 20268-KCurrent reportBylaws amended
- Jun 26, 202610-KAnnual report · period to Mar 2026
- Jun 26, 20268-KCurrent reportResults of operations · Bylaws amended · Regulation FD disclosure
- Jun 22, 20268-KCurrent reportShareholder vote · Other events
Official filings of Beyond Air, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $8 M
- Operating income
- $-29 M
- Net income
- $-33 M
For year ending March-2026 · source: SEC filing
Balance sheet
- Total assets
- $35 M
- Total liabilities
- $29 M
- Total equity
- $6 M
As of March-2026
Top 23 institutional investors in Beyond Air, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Armistice Capital, LLC | 103,000 | New | 6.18% | $0 M | Nov 16, 2026 |
| 2 | Balyasny Asset Management L.P. | 71,206 | New | 4.27% | $0 M | Nov 16, 2026 |
| 3 | Daytona Street Capital LLC | 17,722 | New | 1.06% | $0 M | Oct 15, 2026 |
| 4 | HRT Financial LP | 12,672 | New | 0.76% | $0 M | Nov 13, 2026 |
| 5 | Bleichroeder LP | 4,325 | New | 0.26% | $0 M | Nov 13, 2026 |
| 6 | Vanguard Capital Management LLC | 3,138 | New | 0.19% | $0 M | Nov 13, 2026 |
| 7 | Vanguard Fiduciary Trust Co | 1,468 | New | 0.09% | $0 M | Nov 13, 2026 |
| 8 | UBS Group AG | 1,281 | New | 0.08% | $0 M | Nov 10, 2026 |
| 9 | Tower Research Capital LLC (TRC) | 1,238 | New | 0.07% | $0 M | Nov 16, 2026 |
| 10 | Jones Financial Companies Lllp | 1,000 | New | 0.06% | $0 M | Nov 13, 2026 |
| 11 | BlackRock, Inc. | 933 | New | 0.06% | $0 M | Nov 13, 2026 |
| 12 | Osaic Holdings, Inc. | 403 | New | 0.02% | $0 M | Nov 12, 2026 |
| 13 | PFS Partners, LLC | 100 | New | 0.01% | $0 M | Oct 21, 2026 |
| 14 | IFP Advisors, Inc | 56 | New | 0.00% | $0 M | Oct 16, 2026 |
| 15 | Robinhood Markets, Inc. | 28 | — | 0.00% | $0 M | Nov 18, 2026 |
| 16 | NewEdge Advisors, LLC | 19 | New | 0.00% | $0 M | Nov 13, 2026 |
| 17 | Group One Trading LLC | 5 | New | 0.00% | $0 M | Nov 10, 2026 |
| 18 | BNP Paribas Financial Markets | 4 | New | 0.00% | $0 M | Nov 12, 2026 |
| 19 | Continuum Advisory, LLC | 3 | New | 0.00% | $0 M | Nov 13, 2026 |
| 20 | Godsey & Gibb, Inc | 2 | New | 0.00% | $0 M | Oct 14, 2026 |
| 21 | Caitong International Asset Management Co., Ltd | 2 | New | 0.00% | $0 M | Oct 29, 2026 |
| 22 | Jpmorgan Chase & Co | 1 | New | 0.00% | $0 M | Nov 12, 2026 |
| 23 | Morgan Stanley | 1 | New | 0.00% | $0 M | Nov 13, 2026 |
Mutual funds holding Beyond Air, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 102,787 | $0 M | — | <0.01% | +72% | May 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 62,741 | $0 M | — | <0.01% | +96% | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 8,134 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 6,356 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 1,698 | $0 M | — | <0.01% | no change | May 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jun 30, 2026. The 5 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Beyond Air, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Yi-Chien Lin10% owner | Buy | +2,607 | $2.210 | $6 K | 148,000 | Form 4 |
| filed | Yi-Chien Lin10% owner | Buy | +15,393 | $2.800 | $43 K | 145,393 | Form 4 |
| filed | Yi-Chien Lin10% owner | Buy | +2,000 | $2.710 | $5 K | 130,000 | Form 4 |
| filed | Yi-Chien Lin10% owner | Buy | +3,000 | $2.690 | $8 K | 128,000 | Form 4 |
| filed | Robert Scott GoodmanChief Executive Officer, Director | Buy | +34,722 | $5.760 | $200 K | 34,822 | Form 4 |
| filed | Daniel J. MoorheadChief Financial Officer | Buy | +4,340 | $5.760 | $25 K | 4,340 | Form 4 |
| filed | Steven A. LisiCEO and Chairman of the Board, Director | Buy | +6,000 | $3.250 | $20 K | 3.33 M | Form 4 |
| filed | Robert CareyDirector | Buy | +990,000 | $0.250 | $248 K | 4.07 M | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Beyond Air, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Stock splits: 100-for-1 split
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q4 2017 | Q4 2017 | $0M |
| Q3 2017 | Q3 2017 | $0M |
| Q2 2017 | Q2 2017 | $0M |
| Q1 2017 | Q1 2017 | $0M |
Trading halts
- 2026-08-27 19:57 UTC, code LUDP, resumed 20:00 UTC
- 2026-07-10 23:50 UTC, code T3, resumed 13:00 UTC
- 2025-07-11 23:50 UTC, code T3, resumed 13:00 UTC
Fails to deliver
- : 835 shares at $2.37
- : 3,688 shares at $2.36
- : 1,035 shares at $2.14
- : 2,001 shares at $2.34
- : 974 shares at $2.21
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Beyond Air, Inc. scorecard#
Passes 4 of the 16 checks that could be worked out: strongest in valuation (2 of 4), weakest in profitability (0 of 4). Fiscal year 2025; market cap of Oct 30, 2026.
Valuation2 of 4
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✓Price to book below its peers' median0.6×Price to book 0.6× against Healthcare's median of 3.1×.
- ✓Price to sales below its peers' median0.5×Price to sales 0.5× against Healthcare's median of 3.7×.
- –Free cash flow yield above 5%No free cash flow yield on file.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 4.92% (2026-11-20).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth1 of 3
- ✓Revenue grew in the newest year107.6%Revenue up 107.6% in fiscal 2025.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✗Earnings per share grew in the newest year-4.01 vs -13.77Diluted EPS -4.01 in fiscal 2025 against -13.77 the year before (report's currency).
- ✗Net income higher than five years earlier-$33 M-$33 M in fiscal 2025 against -$23 M in 2020.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability0 of 4
- ✗Profitable in the newest year-$33 MNet income -$33 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-378.1%-378.1% against Medical Equipment's median of -38.5% (8 companies).
- ✗Return on equity above 15%-337.4%-337.4% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health1 of 4
- ✓Short-term assets cover short-term liabilities3.8×Current ratio 3.80 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times-8.2×Operating income -8.2 times interest in fiscal 2025.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-14.44Z-score -14.44 (distress zone) for fiscal 2025.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year145.2%Diluted shares up 145.2% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Medical Equipment, the 10-year Treasury yield of Nov 20, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Beyond Air, Inc.'s statements, beside the median of Medical Equipment.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -378.1% | -38.5% | |
| Net margin | -432.9% | -44.9% | |
| Return on equity | -337.4% | -94.5% | |
| Revenue growth | 107.6% | 15.6% | |
| Free cash flow margin | -249.5% | -35.7% |
6of 8on the Piotroski tests of financial strength
- Net loss of $33 million, the 10th loss-making year in a row.
- Free cash flow was negative: -$19 million.
- The share count rose 145.2% in the year.
- Operating income covers the interest bill only -8.2 times.
Beyond Air, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Mar 31, 2026 | FY 2024to Mar 31, 2025 | FY 2023to Mar 31, 2024 | FY 2022to Mar 31, 2023 | FY 2021to Mar 31, 2022 | FY 2020to Mar 31, 2021 | FY 2019to Mar 31, 2020 | FY 2018to Mar 31, 2019 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 7.7+107%100% | 3.7+220%100% | 1.2—100% | — | — | 0.9r0.9−37.2%100% | 1.4−82.0%100% | 7.7—100% | — | — | |
| Cost of revenue | 7.4+38.4%96.7% | 5.4+118%145% | 2.5+344%213% | 0.6—— | — | — | — | — | — | — | |
| Gross profit | 0.3—3.3% | −1.7—−44.9% | −1.3—−113% | −0.6—— | — | — | — | — | — | — | |
| Research and development | 10−39.2%133% | 17−30.8%455% | 24+44.9%2102% | 17+42.4%— | 12−6.5%— | 13r13+18.5%1445% | 11+171%766% | 3.9−11.5%50.9% | 4.4r4.4+559%— | 0.7—— | |
| Selling, general and administrative | 19−26.8%248% | 26−30.3%702% | 37—3221% | — | — | — | — | — | — | — | |
| General and administrative | — | — | 37+7.6%3221% | 35+88.5%— | 18+75.9%— | 10r10+17.8%1199% | 8.9r0.9+29.6%639% | 6.9+3.4%88.7% | 6.6r6.6+538%— | 1.0r0.1—— | |
| Operating expenses | 29−31.7%382% | 43−30.5%1157% | 62+19.8%5324% | 52+26.5%— | 41—— | — | — | — | — | 0.1—— | |
| Operating income | −29—−378% | −45—−1202% | −63—−5436% | −52—— | −41—— | −22r−22—−2545% | −18—−1305% | −3.1—−39.6% | −11r−11—— | −2.3r−0.1—— | |
| Interest and finance income | 0.3−57.0%3.9% | 0.7−59.5%19.0% | 1.7—150% | — | — | — | — | — | — | — | |
| Interest expense and finance costs | 3.5+16.4%45.8% | 3.0+3.7%81.5% | 2.9+9607%251% | 0.0−96.1%— | 0.8+20.7%— | 0.6r0.6+2002%73.5% | 0.0+1928%2.2% | 0.0−89.9%0.0% | 0.0+1562%— | 0.0—— | |
| Net interest income | — | — | — | — | — | — | — | — | −7.0—— | −1.4—— | |
| Other non-operating income (expense) | −5.3—−68.9% | −3.9—−106% | −1.3—−111% | −7.3—— | −3.4—— | −0.7r−0.7—−75.7% | −2.0—−141% | −3.5—−45.3% | −7.0r−7.0—— | −1.4—— | |
| Income before tax | −34—−447% | −48—−1308% | −64—−5547% | −59—— | −44—— | −23r−23—−2620% | −20—−1446% | −6.6—−85.3% | −18—— | −3.7—— | |
| Income tax | — | — | — | — | — | — | −0.2r0.2—−11.1% | — | — | 0.0—— | |
| Net income including minority interests | −34—−447% | −48—−1308% | −64—−5547% | −59—— | −44—— | −23—−2620% | — | — | — | — | |
| Minority interests' share of net income | −1.1—−14.1% | −1.9—−50.0% | −4.1—−350% | −3.6—— | −0.9—— | — | — | — | — | — | |
| Net income attributable to shareholders | −33—−433% | −47—−1258% | −60—−5198% | −56—— | −43—— | −23r−23—−2620% | −20—−1435% | −6.6—−84.9% | −18r−18—— | −3.7r−0.1—— | |
| Earnings per share, basic | -4.01—— | -13.77r-0.69—— | -1.82—— | -1.86—— | -1.68—— | -1.27—— | -1.78—— | -0.77—— | -3.01—— | -2.69r-0.66—— | |
| Earnings per share, diluted | -4.01—— | -13.77r-0.69—— | -1.82—— | -1.86—— | — | -1.27—— | -1.78—— | -0.77—— | -3.01—— | -2.69r-0.66—— | |
| Shares, weighted average (basic) | 8.3+145%— | 3.4r68−89.8%— | 33+10.6%— | 30+16.8%— | 26r25,668−99.9%— | 18,005—— | — | 8.5+41.6%— | 6.0—— | — | |
| Shares, weighted average (diluted) | 8.3+145%— | 3.4r68−89.8%— | 33+10.6%— | 30—— | — | 18+56.5%— | 12+35.4%— | 8.5+41.6%— | 6.0+314%— | 1.4r0.1—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 6.7+44.5%19.0% | 4.7−59.0%15.5% | 11−61.0%20.0% | 29−63.7%42.4% | 80+132%80.9% | 35r35+74.6%85.5% | 20+1380%72.3% | 1.3+11.5%14.2% | 1.2r1.2+17066%54.9% | 0.0r0.0—3.0% | |
| Short-term investments | 4.9+118%13.9% | 2.3−90.2%7.5% | 23+38.1%40.5% | 17—24.3% | — | — | — | 6.5+980%69.4% | 0.6—27.7% | — | |
| Receivables | 1.1+53.0%3.1% | 0.7+123%2.4% | 0.3−24.0%0.6% | 0.4+30.4%0.6% | 0.3−24.2%0.3% | 0.4—1.0% | — | — | — | — | |
| Inventory | 1.4−41.8%4.0% | 2.4+13.6%8.0% | 2.1+88.4%3.7% | 1.1+223%1.6% | 0.4—0.4% | — | — | — | — | — | |
| Other current assets | 0.2−6.4%0.5% | 0.2r5.7−97.0%0.7% | 6.8+55.5%11.9% | 4.4r1.9+114%6.4% | 2.0r2.4+33.6%2.1% | 1.5r1.5+33.1%3.8% | 1.1+45.8%4.2% | 0.8+1614%8.4% | 0.0+176823%2.1% | 0.0—0.0% | |
| Current assets | 25+54.6%70.0% | 16−63.5%53.3% | 44−26.0%77.1% | 59−36.1%86.4% | 93+150%93.7% | 37r37+39.5%91.9% | 27r27+207%97.3% | 8.7+352%92.2% | 1.9+2161%87.8% | 0.1r0.0—36.0% | |
| Property, plant and equipment | 8.2−25.1%23.3% | 11+17.6%36.6% | 9.4+87.2%16.4% | 5.0+151%7.3% | 2.0+115%2.0% | 0.9r0.9+340%2.3% | 0.2−13.7%0.8% | 0.2−8.3%2.6% | 0.3+338%12.2% | 0.1—25.8% | |
| Right-of-use (leased) assets | 1.2−30.1%3.4% | 1.7−19.6%5.7% | 2.1−14.9%3.7% | 2.5+12.5%3.6% | 2.2+19.1%2.2% | 1.9r1.9+851%4.6% | 0.2r0.1—0.7% | — | — | — | |
| Other intangible assets | 1.0−16.7%2.9% | 1.2−14.4%4.1% | 1.4−12.6%2.5% | 1.6−11.2%2.4% | 1.8+431%1.9% | 0.3r0.4—0.9% | — | — | — | — | |
| Non-current assets | — | — | — | — | — | — | — | — | 0.3+76.8%12.2% | 0.2—64.0% | |
| Total assets | 35+17.7%100% | 30−47.2%100% | 57−17.1%100% | 69−30.7%100% | 99+145%100% | 41r41+47.7%100% | 27+191%100% | 9.4+331%100% | 2.2+828%100% | 0.2r0.0—100% | |
| Accounts payable | 2.4+23.9%6.8% | 2.0+0.1%6.5% | 1.9−3.4%3.4% | 2.0+78.6%2.9% | 1.1−14.8%1.1% | 1.3r1.3−41.3%3.3% | 2.3+93.7%8.2% | 1.2+74.1%12.4% | 0.7+1504%30.6% | 0.0—17.7% | |
| Debt due within a year | — | — | — | — | — | — | — | — | — | 0.0—16.5% | |
| Current liabilities | 6.5+30.2%18.4% | 5.0−56.8%16.6% | 12−41.5%20.3% | 20+84.7%28.8% | 11+182%10.8% | 3.8r3.8−22.0%9.4% | 4.9−9.8%17.8% | 5.4+287%57.3% | 1.4−31.5%63.8% | 2.0r0.1—864% | |
| Lease liabilities (non-current) | 1.0−31.2%2.9% | 1.5−21.7%4.9% | 1.9−18.2%3.3% | 2.3+11.6%3.4% | 2.1+16.2%2.1% | 1.8r1.8+1260%4.4% | 0.1—0.5% | — | — | — | |
| Non-current liabilities | — | — | — | — | — | — | — | — | — | 2.9—1227% | |
| Total liabilities | 29+85.6%82.5% | 16−47.2%52.3% | 30+11.4%52.3% | 27+27.3%38.9% | 21+109%21.2% | 10r10+7.7%24.8% | 9.3+72.9%34.1% | 5.4r0−48.9%57.3% | 11+114%483% | 4.9r0.1—2091% | |
| Retained earnings | −320—−903% | −286—−952% | −240—−421% | −179—−261% | −124—−125% | −80r−80—−199% | −58—−210% | −38—−399% | −32—−1444% | −14r−0.1—−5751% | |
| Shareholders' equity | 6.1−54.9%17.3% | 14−45.8%45.2% | 25−33.9%44.0% | 38−47.9%55.1% | 73+139%73.3% | 30r30+68.4%75.2% | 18r18+350%65.9% | 4.0—42.7% | −8.4r−8.4—−383% | −4.7r−0.1—−1991% | |
| Minority interests | 0.1−88.9%0.2% | 0.8−64.5%2.5% | 2.1−48.0%3.8% | 4.1−25.3%6.0% | 5.5—5.5% | — | — | — | — | — | |
| Total equity | 6.2−56.7%17.5% | 14−47.2%47.7% | 27−35.3%47.7% | 42−46.3%61.1% | 78+157%78.8% | 30+68.4%75.2% | 18—65.9% | — | — | −4.7—−1991% | |
| Total liabilities and equity | 35+17.7%100% | 30−47.2%100% | 57−17.1%100% | 69−30.7%100% | 99+145%100% | 41r41+47.7%100% | 27+191%100% | 9.4+331%100% | 2.2+828%100% | 0.2r0.0—100% | |
| Shares outstanding | 0.6r12−85.7%— | 4.1r83−91.0%— | 46+49.3%— | 31+2.9%— | 30r30+36.9%— | 22+35.9%— | 16+84.2%— | 8.7+42.9%— | 6.1+176%— | 2.2r0.1—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 3.1+3.3%40.4% | 3.0+66.7%81.0% | 1.8+200%155% | 0.6r0.6+91.1%— | 0.3+81.5%— | 0.2r0.2+124%19.8% | 0.1r0.2+19.1%5.6% | 0.1+69.9%0.8% | 0.0—— | — | |
| Share-based compensation | 5.3−42.2%68.8% | 9.1−57.1%247% | 21+9.1%1841% | 20+150%— | 7.8+60.0%— | 4.9r4.9+36.8%561% | 3.6+49.1%257% | 2.4−45.3%31.1% | 4.4r4.4+1101%— | 0.4—— | |
| Cash from operating activities | −18—−236% | −38—−1032% | −56—−4833% | −33—— | −23—— | −20r−20—−2250% | −15−1237%−1097% | 1.3—17.4% | −7.1r−7.1—— | −0.7r0.0—— | |
| Capital expenditure | −1.0—−13.3% | −5.9—−159% | −5.7—−496% | −3.9—— | −1.4—— | −0.9r−0.9—−102% | −0.0—−3.1% | −0.1—−0.7% | −0.2—— | — | |
| Cash from investing activities | −3.7−125%−47.8% | 15—402% | −12—−1056% | −21—— | −1.5—— | −0.9r−0.9−120%−102% | 4.4—318% | −1.8—−23.2% | −1.1r−1.1−8266%— | 0.0—— | |
| Shares issued | 4.5−76.1%58.6% | 19—509% | — | — | 25—— | — | — | 0.8—10.3% | — | — | |
| Shares bought back | — | — | — | — | — | — | — | — | −0.0—— | — | |
| Cash from financing activities | 29+74.8%379% | 17−61.4%449% | 43+1501%3725% | 2.7−96.6%— | 79+162%— | 30r30−13.2%3474% | 35+3160%2513% | 1.1−88.7%13.9% | 9.5r9.5+1602%— | 0.6r−0.0—— | |
| Change in cash | 7.5—97.2% | −6.7—−181% | −25—−2171% | −51−193%— | 55+461%— | 9.8r9.8−59.3%1123% | 24+3795%1734% | 0.6−48.4%8.0% | 1.2r1.2—— | −0.1r−0.0—— | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q2 FY2026to Sep 30, 2026 | Q1 FY2026to Jun 30, 2026 | Q4 FY2025to Mar 31, 2026 | Q3 FY2025to Dec 31, 2025 | Q2 FY2025to Sep 30, 2025 | Q1 FY2025to Jun 30, 2025 | Q4 FY2024to Mar 31, 2025 | Q3 FY2024to Dec 31, 2024 | Q2 FY2024to Sep 30, 2024 | Q1 FY2024to Jun 30, 2024 | Q4 FY2023to Mar 31, 2024 | Q3 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 8.2+41.2%100% | 2.3+27.8%100% | 1.8+0.5%100% | 1.9*+65.5%100% | 2.2+105%100% | 1.8+128%100% | 1.8+158%100% | 1.2*+145%100% | 1.1+174%100% | 0.8—100% | 0.7—100% | 0.5*—100% | 0.4—100% | |
| Cost of revenue | 7.4+19.2%90.0% | 2.1+0.5%91.5% | 1.5−3.8%87.3% | 1.8*+53.1%95.1% | 1.9+47.2%86.3% | 2.1+12.4%116% | 1.6+57.9%91.1% | 1.2*+20.4%103% | 1.3+72.1%120% | 1.9—236% | 1.0—149% | 1.0*—209% | 0.7—191% | |
| Gross profit | 0.8—10.0% | 0.2—8.5% | 0.2+44.2%12.7% | 0.1*—4.9% | 0.3—13.7% | −0.3—−16.4% | 0.2—8.9% | −0.0*—−2.8% | −0.2—−20.1% | −1.1—−136% | −0.3—−48.6% | −0.5*—−109% | −0.4—−91.0% | |
| Research and development | 8.2−30.1%101% | 1.6−35.5%68.0% | 2.0−36.5%111% | 2.3*−30.1%119% | 2.4−19.2%111% | 2.5−46.6%135% | 3.1−48.6%175% | 3.3*−42.8%283% | 3.0−56.1%280% | 4.6—575% | 6.0—880% | 5.7*—1213% | 6.8—1749% | |
| Selling, general and administrative | 19−10.8%231% | 4.6−6.6%198% | 4.9+4.1%276% | 5.0*+28.4%262% | 4.5−42.2%204% | 4.9−31.4%270% | 4.7−35.3%266% | 3.9*−39.5%337% | 7.7−20.8%721% | 7.2—898% | 7.2—1060% | 6.4*—1366% | 9.8—2498% | |
| General and administrative | — | — | — | — | — | — | — | — | — | — | — | 6.4*—1366% | 9.8—2498% | |
| Operating expenses | 27−17.7%332% | 6.2−16.2%266% | 6.8−12.0%387% | 7.3*+1.7%381% | 6.9−35.8%314% | 7.4−37.3%405% | 7.8−41.3%442% | 7.1*−41.1%620% | 11−35.3%1002% | 12—1472% | 13—1940% | 12*—2579% | 17—4247% | |
| Operating income | −26—−322% | −6.0—−257% | −6.6—−374% | −7.2*—−376% | −6.6—−301% | −7.7—−421% | −7.6—−433% | −7.2*—−623% | −11—−1022% | −13—−1608% | −14—−1988% | −13*—−2688% | −17—−4338% | |
| Interest and finance income | 0.4+46.6%5.0% | 0.1+57.6%4.0% | 0.1+268%5.8% | 0.1*+67.6%6.0% | 0.1−19.0%4.6% | 0.1−60.7%3.2% | 0.0−92.2%1.6% | 0.1*−77.4%5.9% | 0.1−67.5%11.8% | 0.2—18.8% | 0.4—52.9% | 0.3*—64.0% | 0.4—99.2% | |
| Interest expense and finance costs | 5.3+130%65.0% | 1.5+135%64.7% | 1.5+172%84.4% | 1.2*+114%65.0% | 1.1+98.2%49.6% | 0.6−31.1%35.1% | 0.5−43.2%31.1% | 0.6*−37.0%50.3% | 0.5−40.3%51.2% | 0.9—116% | 1.0—141% | 0.9*—196% | 0.9—235% | |
| Other non-operating income (expense) | −8.0—−97.3% | −2.2—−94.7% | −1.5—−87.2% | −3.2*—−168% | −1.0—−47.1% | −0.6—−32.8% | −0.5−188%−26.2% | −0.9*—−77.3% | −2.4—−222% | −1.2—−150% | 0.5—76.9% | −1.9*—−409% | −0.3—−75.2% | |
| Income before tax | −34—−419% | −8.2—−352% | −8.2—−461% | −10*—−544% | −7.6—−348% | −8.3—−454% | −8.1—−459% | −8.1*—−700% | −13—−1244% | −14—−1758% | −13—−1911% | −15*—−3097% | −17—−4414% | |
| Net income including minority interests | −34—−419% | −8.2—−352% | −8.2—−461% | −10*—−544% | −7.6—−348% | −8.3—−454% | −8.1—−459% | −8.1*—−700% | −13—−1244% | −14—−1758% | −13—−1911% | −15*—−3097% | −17—−4414% | |
| Minority interests' share of net income | −1.0—−11.7% | −0.4—−15.4% | −0.2—−12.4% | −0.1*—−4.5% | −0.3—−13.4% | −0.3—−17.5% | −0.4—−22.0% | −0.0*—−2.5% | −0.3—−28.0% | −0.7—−84.1% | −0.9—−125% | −0.8*—−181% | −1.0—−265% | |
| Net income attributable to shareholders | −33—−407% | −7.8—−336% | −7.9—−449% | −10*—−539% | −7.3—−334% | −7.9—−437% | −7.7—−437% | −8.0*—−697% | −13—−1216% | −13—−1674% | −12—−1786% | −14*—−2916% | −16—−4148% | |
| Earnings per share, basic | — | -3.76—— | -11.00—— | — | -0.85—— | -24.98r-1.25—— | -30.67r-1.53—— | — | -2.96r-0.15—— | -5.67r-0.28—— | -5.32r-0.27—— | — | -0.50—— | |
| Earnings per share, diluted | — | -3.76—— | -11.00—— | — | -0.85—— | -24.98r-1.25—— | -30.67r-1.53—— | — | -2.96r-0.15—— | -5.67r-0.28—— | -5.32r-0.27—— | — | -0.50—— | |
| Shares, weighted average (basic) | 2.1+554%— | 2.1+554%— | 0.7+188%— | — | 8.6+95.7%— | 0.3r6.4−86.5%— | 0.3r5.0−89.1%— | — | 4.4r88−86.4%— | 2.4r47—— | 2.3r46—— | — | 32—— | |
| Shares, weighted average (diluted) | 2.1+554%— | 2.1+554%— | 0.7+188%— | — | 8.6+95.7%— | 0.3r6.4−86.5%— | 0.3r5.0−89.1%— | — | 4.4r88−86.4%— | 2.4r47—— | 2.3r46—— | — | 32—— | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 5.4—14.9% | 5.4−44.4%14.9% | 5.5+10.7%16.7% | 6.7+44.5%19.0% | 6.6+44.4%18.1% | 9.7−65.9%31.3% | 5.0+19.6%17.7% | 4.7−59.0%15.5% | 4.6−42.3%13.5% | 28—53.7% | 4.2—8.9% | 11—20.0% | 8.0—15.4% | |
| Short-term investments | 5.7—15.6% | 5.7+467%15.6% | 4.3+189%13.1% | 4.9+118%13.9% | 5.0−21.0%13.6% | 1.0—3.2% | 1.5−91.4%5.3% | 2.3−90.2%7.5% | 6.3−72.7%18.6% | — | 17—37.0% | 23—40.5% | 23—44.9% | |
| Receivables | 1.5—4.0% | 1.5+62.6%4.0% | 1.1+41.8%3.5% | 1.1+53.0%3.1% | 1.2+80.1%3.1% | 0.9+60.4%2.9% | 0.8+69.3%2.9% | 0.7+123%2.4% | 0.6+117%1.9% | 0.6—1.0% | 0.5—1.0% | 0.3—0.6% | 0.3—0.6% | |
| Inventory | 1.2—3.3% | 1.2−46.6%3.3% | 1.3−46.9%3.9% | 1.4−41.8%4.0% | 1.8−26.0%4.8% | 2.2−11.8%7.2% | 2.4+1.8%8.7% | 2.4+13.6%8.0% | 2.4+55.2%7.0% | 2.5—4.8% | 2.4—5.1% | 2.1—3.7% | 1.5—3.0% | |
| Other current assets | 0.2—0.5% | 0.2−96.2%0.5% | 0.2−96.0%0.6% | 0.2−6.4%0.5% | 0.1−97.6%0.3% | 4.6−26.6%14.9% | 5.1−20.0%18.2% | 0.2r5.7−97.0%0.7% | 5.1−15.9%15.1% | 6.3—11.8% | 6.4—13.8% | 6.8—11.9% | 6.1—11.8% | |
| Current assets | 27—73.4% | 27+43.3%73.4% | 23+52.4%69.5% | 25+54.6%70.0% | 26+32.2%69.5% | 19−51.1%60.0% | 15−51.5%53.3% | 16−63.5%53.3% | 19−51.0%56.7% | 38—71.8% | 31—66.4% | 44—77.1% | 39—76.0% | |
| Property, plant and equipment | 7.6—21.1% | 7.6−18.7%21.1% | 7.9−22.3%24.1% | 8.2−25.1%23.3% | 8.5−27.0%23.1% | 9.4−19.4%30.3% | 10−15.9%36.2% | 11+17.6%36.6% | 12+36.3%34.1% | 12—22.0% | 12—26.1% | 9.4—16.4% | 8.6—16.5% | |
| Right-of-use (leased) assets | 1.0—2.8% | 1.0−35.7%2.8% | 1.1−35.6%3.2% | 1.2−30.1%3.4% | 1.5−17.5%4.0% | 1.6−17.7%5.0% | 1.7−18.2%5.9% | 1.7−19.6%5.7% | 1.8−20.4%5.2% | 1.9—3.6% | 2.0—4.3% | 2.1—3.7% | 2.2—4.3% | |
| Other intangible assets | — | — | — | 1.0−16.7%2.9% | — | — | — | 1.2−14.4%4.1% | — | — | — | 1.4—2.5% | 1.5—2.8% | |
| Total assets | 36—100% | 36+17.1%100% | 33+17.0%100% | 35+17.7%100% | 37+7.7%100% | 31−41.6%100% | 28−39.5%100% | 30−47.2%100% | 34−34.2%100% | 53—100% | 47—100% | 57—100% | 52—100% | |
| Accounts payable | 2.1—5.9% | 2.1+11.1%5.9% | 2.5+97.7%7.5% | 2.4+23.9%6.8% | 2.2−6.6%6.0% | 1.9+28.5%6.2% | 1.2−60.1%4.4% | 2.0+0.1%6.5% | 2.4−26.8%6.9% | 1.5—2.8% | 3.1—6.7% | 1.9—3.4% | 3.2—6.2% | |
| Current liabilities | 7.3—20.0% | 7.3+65.4%20.0% | 6.9+49.3%21.0% | 6.5+30.2%18.4% | 5.0−8.1%13.6% | 4.4−33.6%14.2% | 4.6−60.6%16.5% | 5.0−56.8%16.6% | 5.4−53.4%15.9% | 6.6—12.4% | 12—25.3% | 12—20.3% | 12—22.4% | |
| Lease liabilities (non-current) | 0.9—2.5% | 0.9−30.8%2.5% | 1.0−31.1%3.0% | 1.0−31.2%2.9% | 1.2−21.4%3.3% | 1.3−23.1%4.2% | 1.4−20.7%5.0% | 1.5−21.7%4.9% | 1.6−22.1%4.6% | 1.7—3.2% | 1.8—3.8% | 1.9—3.3% | 2.0—3.9% | |
| Total liabilities | 30—83.1% | 30+68.6%83.1% | 30+69.7%91.4% | 29+85.6%82.5% | 28+80.7%77.5% | 18−24.7%57.7% | 18−38.5%63.0% | 16−47.2%52.3% | 16−44.6%46.2% | 24—44.7% | 29—61.9% | 30—52.3% | 28—54.8% | |
| Retained earnings | −335—−925% | −335—−925% | −328—−996% | −320—−903% | −309—−841% | −302—−975% | −294—−1046% | −286—−952% | −278—−815% | −265—−500% | −252—−542% | −240—−421% | −226—−435% | |
| Shareholders' equity | 5.3—14.7% | 5.3−58.2%14.7% | 2.0−79.9%6.1% | 6.1−54.9%17.3% | 8.1−54.0%22.1% | 13−54.7%41.1% | 9.9−38.5%35.3% | 14−45.8%45.2% | 18−15.2%51.7% | 28—53.1% | 16—34.7% | 25—44.0% | 21—40.1% | |
| Minority interests | 0.8—2.2% | 0.8+120%2.2% | 0.8+75.1%2.6% | 0.1−88.9%0.2% | 0.2−76.3%0.5% | 0.4−69.0%1.2% | 0.5−69.4%1.7% | 0.8−64.5%2.5% | 0.7−72.2%2.2% | 1.2—2.2% | 1.6—3.4% | 2.1—3.8% | 2.7—5.1% | |
| Total equity | 6.1—16.9% | 6.1−53.2%16.9% | 2.8−72.7%8.6% | 6.2−56.7%17.5% | 8.3−54.9%22.5% | 13−55.3%42.3% | 10−41.2%37.0% | 14−47.2%47.7% | 18−21.7%53.8% | 29—55.3% | 18—38.1% | 27—47.7% | 23—45.2% | |
| Total liabilities and equity | 36—100% | 36+17.1%100% | 33+17.0%100% | 35+17.7%100% | 37+7.7%100% | 31−41.6%100% | 28−39.5%100% | 30−47.2%100% | 34−34.2%100% | 53—100% | 47—100% | 57—100% | 52—100% | |
| Shares outstanding | 1.6—— | 1.6−79.8%— | 0.7−84.2%— | 0.6r12−85.7%— | 8.4−88.7%— | 8.0−88.9%— | 4.7−89.8%— | 4.1r83−91.0%— | 74+110%— | 72—— | 46—— | 46—— | 35—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 3.20.0%39.1% | 0.80.0%34.4% | 0.80.0%45.2% | 0.8*0.0%42.0% | 0.80.0%36.5% | 0.80.0%44.0% | 0.8+14.3%45.5% | 0.8r0.8*+30.1%69.4% | 0.8+100%74.6% | 0.8—100% | 0.7r0.7—102% | 0.6*—131% | 0.4r0.5—102% | |
| Share-based compensation | 3.4−43.4%41.4% | 0.4−76.0%18.3% | 1.0−34.3%58.6% | 0.4*+170%22.4% | 1.5−39.4%68.5% | 1.8−43.3%97.6% | 1.6−53.3%89.6% | 0.2*−93.2%13.7% | 2.5−61.5%231% | 3.1—392% | 3.4—495% | 2.3*—495% | 6.4—1646% | |
| Cash from operating activities | −20—−240% | −5.6*—−240% | −4.9—−280% | −4.9*—−259% | −4.2*—−192% | −4.5*—−245% | −4.5—−257% | −7.0*—−604% | −7.7*—−721% | −13*—−1673% | −10—−1490% | −11*—−2282% | −14*—−3534% | |
| Capital expenditure | −1.5—−18.8% | −0.8*—−32.3% | −0.2—−11.8% | −0.5*—−28.7% | −0.0*—−1.5% | −0.2*—−13.5% | −0.2—−11.3% | −1.5*—−130% | −0.5*—−50.1% | −1.2*—−147% | −2.7—−391% | −1.9*—−411% | −1.3*—−342% | |
| Cash from investing activities | −6.1—−74.9% | −2.1*−979%−90.7% | 0.5−20.0%26.1% | −0.4*−117%−23.4% | −4.0*—−184% | 0.2*−98.5%13.2% | 0.6−81.5%32.7% | 2.6*—224% | −6.9*−913%−647% | 16*—2023% | 3.1—456% | −1.7*—−355% | 0.9*—218% | |
| Debt issued | — | — | — | — | — | — | — | — | — | 0*—0.0% | 0.1—14.6% | — | — | |
| Shares issued | — | — | — | 3.8*—199% | — | — | — | 0*—0.0% | 0*—0.0% | — | — | — | 0r5.5*—0.0% | |
| Cash from financing activities | 29+249%352% | 9.7*+8.6%417% | 3.1−24.8%173% | 4.9*+8.9%257% | 11*—511% | 8.9*−58.8%491% | 4.1—231% | 4.5*−71.7%391% | −9.2*−276%−860% | 22*—2710% | −0.3—−38.7% | 16*—3381% | 5.2*—1340% | |
| Change in cash | 3.0—36.9% | 2.0*−58.3%84.8% | −1.4−696%−81.9% | −0.5*−831%−24.5% | 3.0*—135% | 4.7*−80.6%260% | 0.2—13.8% | 0.1*−98.1%5.6% | −24*—−2224% | 24*—3043% | −7.2—−1057% | 3.4*—724% | −7.7*—−1966% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Where Beyond Air, Inc. operates: 6 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 10 subsidiaries on file.
| Country | Presence | Revenue there |
|---|---|---|
| 🇺🇸 USA | Headquarters1 office2 subsidiaries | — |
| 🇮🇱 Israel | 3 subsidiaries | — |
| 🇮🇪 Ireland | 2 subsidiaries | — |
| 🇦🇺 Australia | 1 subsidiary | — |
| 🇧🇲 Bermuda | 1 subsidiary | — |
| 🇨🇾 Cyprus | 1 subsidiary | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Executive pay at Beyond Air, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2026Robert Scott Goodman | $758 K | −$1.3 M | $377 K | $1 |
| 2025Robert Scott Goodman | $821 K | −$787 K | $435 K | $4 |
| 2024Robert Scott Goodman | $1.7 M | −$4.1 M | $875 K | $26 |
Source: SEC proxy statement (Form DEF 14A) · as of Mar 31, 2026
Events at Beyond Air, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
- Delisting noticeFiling
Delisting notice 1 · Directors and officers 7 · Material agreement 7 · New debt 1 · Unregistered share sale 4 · Shareholder rights changed 2 · Bylaws or fiscal year changed 3 · Shareholder vote 3 · Results announced 7
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Directors and officersMaterial agreement | 8-K | |
| Results announced | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Shareholder rights changedBylaws or fiscal year changed | 8-K | |
| Bylaws or fiscal year changedResults announced | 8-K | |
| Shareholder vote | 8-K | |
| Delisting notice | 8-K | |
| Directors and officersMaterial agreement | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Directors and officersMaterial agreement | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Directors and officersMaterial agreementNew debtUnregistered share sale | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Shareholder rights changedBylaws or fiscal year changed | 8-K | |
| Shareholder vote | 8-K | |
| Directors and officersResults announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Oct 8, 2026
Acquisitions and funding#
1 private funding rounds before listing
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2024 | $21 M | Private placement after listing | $10 to $50 million | 15 | equity, options | SEC |
| Jun 2023 | $1 M | Private placement after listing | Under $2 million | 2 | equity, options | SEC |
| Jun 2019 | $8 M | Private placement after listing | $2 to $10 million | 47 | equity | SEC |
| Feb 2018 | $10 M | No. 1 | $2 to $10 million | 58 | options | SEC |
| Jan 2017 | $37 M | Issued in a merger or acquisition | $10 to $50 million | 58 | equity, options | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
How Beyond Air, Inc. compares in Medical Equipment
- Market cap$4 M · higher than 0% of 8
- Revenue$8 M · higher than 11% of 19
- Net margin-407.6% · higher than 0% of 17
- Revenue growth107.6% · highest of 13
- Price / sales0.5× · lower than 83% of 7
- Price / book0.6× · lower than 83% of 7
- 🇺🇸 IRIDEX Corporation$12 M
- 🇺🇸 TELA Bio, Inc.$52 M
- 🇺🇸 Streamex Corp.$52 M
- 🇨🇦 Profound Medical Corp.$240 M
- 🇺🇸 Electromed, Inc.$341 M
- 🇺🇸 Viemed Healthcare, Inc.$367 M
Peer comparison · Medical Equipment
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Beyond Air, Inc.🇺🇸 | $4 M | — | -407.6% | +107.6% |
| Avita Medical, Inc.🇺🇸 | $525 M | — | -42.6% | +11.5% |
| Viemed Healthcare, Inc.🇺🇸 | $367 M | 23.5× | 5.0% | +20.5% |
| Electromed, Inc.🇺🇸 | $341 M | 28.6× | 15.8% | +15.3% |
| Profound Medical Corp.🇨🇦 | $240 M | — | -137.4% | +50.8% |
| Streamex Corp.🇺🇸 | $52 M | — | — | +100.0% |
| TELA Bio, Inc.🇺🇸 | $52 M | — | -53.6% | +15.8% |
| IRIDEX Corporation🇺🇸 | $12 M | — | -6.9% | +8.2% |
| Varian Medical Systems🇺🇸 | $16.3 B | — | 8.5% | -1.8% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- IRIDEX Corporation$12 M
- TELA Bio, Inc.$52 M
- Streamex Corp.$52 M
- Profound Medical Corp.$240 M
- Electromed, Inc.$341 M
- Viemed Healthcare, Inc.$367 M
Sources and freshness
- Market cap:
- Oct 30, 2026
- Annual results:
- For year ending March-2026
- Balance sheet:
- As of March-2026
- Employees:
- As of March 31, 2026
- Profile updated:
- Nov 21, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report, GLEIF register; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Beyond Air, Inc.? Verify and update this profile — free
Show Beyond Air, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.